Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation
Axonal growth inhibitors are released during traumatic injuries to the adult mammalian central nervous system, including after spinal cord injury. These molecules accumulate at the injury site and form a highly inhibitory environment for axonal regeneration. Among these inhibitory molecules, myelin-...
Main Authors: | Sílvia Sousa Chambel, Célia Duarte Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=12;spage=2573;epage=2581;aulast=Chambel |
Similar Items
-
How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
by: Zahra Rashidbenam, et al.
Published: (2023-06-01) -
Editorial: Myelin-Mediated Inhibition of Axonal Regeneration: Past, Present, and Future
by: Wilfredo Mellado, et al.
Published: (2017-04-01) -
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
by: Min Joung Kim, et al.
Published: (2018-12-01) -
Plasticity-Enhancing Effects of Levodopa Treatment after Stroke
by: Daniela Talhada, et al.
Published: (2021-09-01) -
Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
by: Yi Hua, et al.
Published: (2023-08-01)